Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.
Market Cap
$3.50B
P/E Ratio
-8.8
1Y Stock Return
33.66%
1Y Revenue Growth
-100.00%
Dividend Yield
0.00%
Price to Book
2.7
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Finnhub
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On November 12, 2024, the Board of Directors of Denali Therapeutics Inc. , acting upon the...
SeekingAlpha
Denali Therapeutics' innovative approach to neurological disorders and strong financial strategy position it as a leader in the field of neurodegenerative diseases. Read more here.
Yahoo
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Yahoo
DNLI reports a wider-than-expected loss in the third quarter of 2024. Nonetheless, the pipeline progress has been encouraging.
Yahoo
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the third quarter ended September 30, 2024, and provided business highlights. "As leaders in pioneering a new class of therapeutics that cross the blood-brain barrier, we are making significant progress across our Transport Vehicle (TV)-enabled portfolio,” said Ryan Watts, Ph.D., Chief Executive Officer of Denali Therapeutics. “Within our Enzyme TV (ETV) fra
Finnhub
Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights SOUTH SAN FRANCISCO, Calif., - November 6, 2024 - Denali Therapeutics Inc. today reported...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BEAM | 65.10% | $2.09B | -9.52% | 0.00% |
DORM | 59.39% | $4.14B | +89.68% | 0.00% |
LGND | 57.16% | $2.11B | +91.18% | 0.00% |
HSII | 56.01% | $914.74M | +64.66% | 1.35% |
ALEC | 55.72% | $377.04M | -19.46% | 0.00% |
VKTX | 54.80% | $5.74B | +353.83% | 0.00% |
NTLA | 54.36% | $1.44B | -50.35% | 0.00% |
AHCO | 51.11% | $1.31B | +17.07% | 0.00% |
PRTA | 50.06% | $756.01M | -56.52% | 0.00% |
RCKT | 50.06% | $1.20B | -39.83% | 0.00% |
PGEN | 49.43% | $228.91M | -28.00% | 0.00% |
HASI | 49.35% | $3.29B | +16.65% | 5.90% |
CWH | 48.88% | $1.36B | +5.90% | 2.22% |
CDXS | 48.72% | $345.86M | +121.35% | 0.00% |
GMRE | 48.49% | $579.18M | -10.99% | 9.69% |
XHR | 48.08% | $1.51B | +19.71% | 3.13% |
CRSP | 47.80% | $4.01B | -30.49% | 0.00% |
MYGN | 47.55% | $1.37B | -14.19% | 0.00% |
DEA | 47.46% | $1.27B | +5.51% | 8.82% |
NCLH | 47.23% | $11.58B | +83.81% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NERV | -19.77% | $14.69M | -58.00% | 0.00% |
TCTM | -15.16% | $8.10M | -42.99% | 0.00% |
PGR | -14.34% | $149.10B | +57.29% | 0.45% |
MCK | -14.16% | $78.15B | +35.51% | 0.42% |
COR | -12.51% | $47.48B | +21.20% | 0.86% |
CME | -11.29% | $82.76B | +9.21% | 1.98% |
CHD | -10.66% | $27.18B | +19.50% | 1.03% |
HUSA | -9.67% | $16.69M | -11.56% | 0.00% |
CBOE | -8.70% | $21.46B | +15.84% | 1.11% |
CCEC | -7.58% | $1.02B | +28.03% | 3.26% |
BTCT | -7.42% | $42.61M | +353.33% | 0.00% |
ASUR | -7.17% | $233.14M | +12.13% | 0.00% |
PRT | -6.53% | $48.72M | -16.56% | 10.33% |
TEM | -6.38% | $8.50B | 0.00% | 0.00% |
STG | -5.63% | $35.67M | +7.92% | 0.00% |
PULM | -5.43% | $19.83M | +202.98% | 0.00% |
ACGL | -5.16% | $36.00B | +16.84% | 0.00% |
PG | -5.05% | $402.15B | +14.14% | 2.33% |
GIS | -4.94% | $34.85B | -2.91% | 3.78% |
PRGO | -4.33% | $3.72B | -9.95% | 4.04% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FSK | 0.05% | - | - | 11.89% |
OCX | -0.11% | $42.93M | -36.09% | 0.00% |
STVN | 0.22% | $4.95B | -32.48% | 0.32% |
CPSH | 0.22% | $20.70M | -40.13% | 0.00% |
MSDL | 0.25% | $1.83B | +0.66% | 7.26% |
SCKT | -0.25% | $10.88M | +15.32% | 0.00% |
MASI | -0.28% | $8.75B | +73.22% | 0.00% |
VERX | -0.28% | $7.99B | +89.70% | 0.00% |
WRB | -0.34% | $22.94B | +29.98% | 0.69% |
VNOM | 0.42% | $5.48B | +79.62% | 3.35% |
VIST | -0.46% | $4.75B | +67.10% | 0.00% |
WLKP | 0.51% | $796.39M | +4.00% | 8.34% |
HQY | 0.54% | $8.97B | +52.15% | 0.00% |
CMG | 0.57% | $80.02B | +33.62% | 0.00% |
LUMO | -0.58% | $37.45M | +41.97% | 0.00% |
TEO | 0.73% | $1.69B | +87.97% | 0.00% |
GL | 0.79% | $9.18B | -8.60% | 0.86% |
ASPS | 0.81% | $22.36M | -80.26% | 0.00% |
PTMN | 0.91% | - | - | 16.06% |
ADBE | 0.92% | $219.93B | -18.23% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -49.24% | $388.04M | 1.43% |
VIXY | -24.27% | $195.31M | 0.85% |
USDU | -23.61% | $201.97M | 0.5% |
UUP | -19.67% | $309.25M | 0.77% |
CTA | -11.14% | $350.27M | 0.78% |
TAIL | -10.25% | $67.98M | 0.59% |
KMLM | -8.93% | $353.87M | 0.9% |
BILZ | -8.49% | $563.02M | 0.14% |
EQLS | -8.16% | $76.08M | 1% |
HDRO | -7.87% | $164.26M | 0.3% |
KCCA | -6.59% | $220.51M | 0.87% |
BSCO | -5.87% | $2.35B | 0.1% |
DBE | -5.80% | $50.13M | 0.77% |
DBMF | -3.37% | $1.02B | 0.85% |
JBBB | -3.03% | $1.26B | 0.49% |
MINT | -3.00% | $11.62B | 0.35% |
CSHI | -2.63% | $482.85M | 0.38% |
TBIL | -2.12% | $4.38B | 0.15% |
CORN | -2.05% | $61.12M | 0.2% |
CLOI | -1.48% | $715.40M | 0.4% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
WEAT | 0.39% | $120.27M | 0.28% |
HIGH | 0.40% | $302.78M | 0.51% |
GBIL | -0.58% | $5.60B | 0.12% |
BOXX | -0.65% | $4.43B | 0.1949% |
DBO | -0.78% | $217.57M | 0.77% |
JUCY | -0.89% | $324.29M | 0.6% |
DBA | -1.28% | $755.88M | 0.93% |
CLOI | -1.48% | $715.40M | 0.4% |
CORN | -2.05% | $61.12M | 0.2% |
TBIL | -2.12% | $4.38B | 0.15% |
XBIL | 2.24% | $637.70M | 0.15% |
COMT | 2.42% | $829.06M | 0.48% |
CSHI | -2.63% | $482.85M | 0.38% |
SGOV | 2.84% | $27.53B | 0.09% |
MINT | -3.00% | $11.62B | 0.35% |
JBBB | -3.03% | $1.26B | 0.49% |
TBLL | 3.18% | $1.92B | 0.08% |
GSG | 3.22% | $914.42M | 0.75% |
FLTR | 3.29% | $1.79B | 0.14% |
USCI | 3.35% | $185.47M | 1.07% |
Current Value
$24.181 Year Return
Current Value
$24.181 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 68.66% | $6.58B | 0.35% |
GNOM | 65.54% | $70.59M | 0.5% |
ARKG | 62.13% | $1.13B | 0.75% |
IBB | 61.50% | $6.66B | 0.45% |
PTH | 60.59% | $143.31M | 0.6% |
PBE | 57.43% | $258.53M | 0.58% |
FBT | 57.31% | $1.11B | 0.56% |
IWO | 57.26% | $12.56B | 0.24% |
IWC | 56.69% | $933.99M | 0.6% |
IWM | 56.42% | $75.73B | 0.19% |
VTWO | 56.33% | $12.38B | 0.1% |
ISCG | 55.78% | $640.00M | 0.06% |
XPH | 55.67% | $157.87M | 0.35% |
RSPA | 54.92% | $273.87M | 0% |
ESML | 54.77% | $1.90B | 0.17% |
SMMD | 54.47% | $1.24B | 0.15% |
EES | 53.98% | $668.71M | 0.38% |
NUSC | 53.85% | $1.27B | 0.31% |
IBUY | 53.77% | $176.17M | 0.65% |
IWN | 53.42% | $13.17B | 0.24% |